Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-26 Sale |
2024-11-27 4:24 pm |
Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer |
44 | $4.865 | $214 | 235,066 (Indirect Direct) |
View |
| 2024-03-15 Sale |
2024-03-19 2:30 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
50,000 | $6 | $300,000 | 984,476 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-12 1:45 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
25,000 | $5.1874 | $129,685 | 1,034,476 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-10 Tax Withholding |
2025-03-11 5:49 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer |
4,572 | $2.54 | 408,552 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-11 5:49 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer |
28,290 | $2.65 | 408,552 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 5:49 pm |
N/A 2035-03-07 |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer |
180,000 | $0 | 408,552 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-11 5:48 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer |
2,182 | $2.54 | 337,526 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-11 5:48 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer |
15,358 | $2.65 | 337,526 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 5:48 pm |
N/A 2035-03-07 |
Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer |
120,000 | $0 | 337,526 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-11 5:48 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer |
18,929 | $2.65 | 399,366 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 5:48 pm |
N/A 2035-03-07 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer |
170,000 | $0 | 399,366 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-11 5:48 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer |
8,115 | $2.65 | 343,566 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 5:48 pm |
N/A 2035-03-07 |
Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer |
100,000 | $0 | 343,566 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-11 5:48 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing |
5,428 | $2.65 | 194,572 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 5:48 pm |
N/A 2035-03-07 |
Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing |
125,000 | $0 | 194,572 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-11 5:47 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer |
20,250 | $2.65 | 462,981 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 5:47 pm |
N/A 2035-03-07 |
Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer |
170,000 | $0 | 462,981 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-11 5:47 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Boyd Peter E. See Remark |
14,305 | $2.65 | 343,323 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 5:47 pm |
N/A 2035-03-07 |
Aquestive Therapeutics Inc. | AQST | Boyd Peter E. See Remark |
120,000 | $0 | 343,323 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-11 5:47 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO |
83,305 | $2.65 | 1,423,173 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 5:47 pm |
N/A 2025-03-07 |
Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO |
680,000 | $0 | 1,423,173 (Direct) |
View |
| 2024-12-02 Gift |
2024-12-04 4:47 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K 10% Owner |
40,000 | $0 | 10,026,111 (Indirect) |
View |
| 2024-03-09 Tax Withholding(A) |
2024-10-02 2:16 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
9,645 | $4.88 | 980,726 (Direct) |
View |
| 2024-03-09 Tax Withholding(A) |
2024-10-02 2:15 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer |
19,505 | $4.88 | 261,414 (Direct) |
View |
| 2024-03-09 Tax Withholding(A) |
2024-10-02 2:15 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO |
56,824 | $4.88 | 826,478 (Direct) |
View |
| 2024-03-09 Tax Withholding(A) |
2024-10-02 2:14 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Jung Cassie SVP, Operations |
14,120 | $4.88 | 235,110 (Direct) |
View |
| 2024-08-09 Tax Withholding |
2024-08-12 2:45 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer |
10,819 | $3.43 | 251,681 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 1:51 pm |
2025-06-20 2034-06-20 |
Aquestive Therapeutics Inc. | AQST | MORRIS TIMOTHY E Director |
38,000 | $0 | 38,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 1:51 pm |
2025-06-20 2034-06-20 |
Aquestive Therapeutics Inc. | AQST | Taglietti Marco Director |
38,000 | $0 | 38,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 1:51 pm |
2025-06-20 2034-06-20 |
Aquestive Therapeutics Inc. | AQST | BROWN GREGORY B Director |
38,000 | $0 | 113,085 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 1:50 pm |
2025-06-20 2034-06-20 |
Aquestive Therapeutics Inc. | AQST | Krop Julie Director |
38,000 | $0 | 38,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 1:50 pm |
2025-06-20 2034-06-20 |
Aquestive Therapeutics Inc. | AQST | Cochran John Director |
38,000 | $0 | 137,486 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-21 1:50 pm |
2025-06-20 2034-06-20 |
Aquestive Therapeutics Inc. | AQST | COSTA SANTO J Director |
38,000 | $0 | 55,327 (Direct) |
View |
Ownership(A) |
2024-06-12 5:14 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing |
0 | $0 | 50,000 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 12:36 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing |
25,000 | $0 | 25,000 (Direct) |
View |
Ownership |
2024-06-11 12:35 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing |
0 | $0 | 0 (Direct) |
View |
| 2024-05-10 Option Award |
2024-05-13 1:40 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer |
10,000 | $0 | 267,963 (Direct) |
View |
| 2024-05-10 Option Award |
2024-05-13 1:40 pm |
N/A 2034-05-10 |
Aquestive Therapeutics Inc. | AQST | Jenkins Abigail L. Director |
57,000 | $0 | 57,000 (Direct) |
View |
Ownership |
2024-04-26 09:20 am |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Jenkins Abigail L. Director |
0 | $0 | 0 (Direct) |
View |
| 2024-03-09 Tax Withholding |
2024-03-12 1:47 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO |
37,938 | $4.88 | 845,364 (Direct) |
View |
| 2024-03-09 Tax Withholding |
2024-03-12 1:47 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Boyd Peter E. See Remark |
8,370 | $4.88 | 237,628 (Direct) |
View |
| 2024-03-09 Tax Withholding |
2024-03-12 1:47 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J SVP, General Counsel |
10,530 | $4.88 | 313,231 (Direct) |
View |
| 2024-03-09 Tax Withholding |
2024-03-12 1:47 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer |
11,705 | $4.88 | 248,295 (Direct) |
View |
| 2024-03-09 Tax Withholding |
2024-03-12 1:46 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development |
12,956 | $4.88 | 257,963 (Direct) |
View |
| 2024-03-09 Tax Withholding |
2024-03-12 1:46 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Jung Cassie SVP, Operations |
9,432 | $4.88 | 239,798 (Direct) |
View |
| 2024-03-09 Tax Withholding |
2024-03-12 1:45 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
5,895 | $4.88 | 1,034,476 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 10:36 am |
N/A 2034-03-07 |
Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J SVP, General Counsel |
202,500 | $0 | 391,261 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 10:36 am |
N/A 2034-03-07 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer |
180,000 | $0 | 320,000 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 10:36 am |
N/A 2034-03-07 |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
123,750 | $0 | 1,106,621 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 10:35 am |
N/A 2034-03-07 |
Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer |
168,750 | $0 | 318,750 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 10:35 am |
N/A 2034-03-07 |
Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO |
606,500 | $0 | 1,247,202 (Direct) |
View |